Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

DICYCLOMINE 10 MG/5 ML SOLN

dicyclomine hydrochloride
$0.1780per ML
High Outlier

Strength

10 mg/5mL

Manufacturer

Endo USA Inc.

NDC

00603116158

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DICYCLOMINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA040169

On Market Since

6/23/2005

Pharmacological Classes

Anticholinergic
Cholinergic Antagonists

Price History

1W

0.0%

1M

+1.1%

3M

-4.1%

6M

-4.5%

1Y

-9.6%

3Y

-9.7%

5Y

-19.6%

All

+1.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

IPRATROPIUM BR 0.02% SOLN
Generic
00487980102•Nephron Pharmaceuticals Corporation
$0.0529
per ML
DICYCLOMINE 20 MG TABLET
Generic
00143122701•Hikma Pharmaceuticals USA Inc.
$0.0555
per EA
DICYCLOMINE 20 MG TABLET
Generic
00143122710•Hikma Pharmaceuticals USA Inc.
$0.0555
per EA
DICYCLOMINE 20 MG TABLET
Generic
00527128201•Lannett Company Inc.
$0.0555
per EA
DICYCLOMINE 20 MG TABLET
Generic
00527128210•Lannett Company Inc.
$0.0555
per EA
DICYCLOMINE 20 MG TABLET
Generic
00591079501•Actavis Pharma, Inc.
$0.0555
per EA
DICYCLOMINE 20 MG TABLET
Generic
00591079510•Actavis Pharma, Inc.
$0.0555
per EA
DICYCLOMINE 20 MG TABLET
Generic
00832605210•Upsher-Smith Laboratories LLC
$0.0555
per EA
DICYCLOMINE 20 MG TABLET
Generic
00832605211•Upsher-Smith Laboratories LLC
$0.0555
per EA
DICYCLOMINE 20 MG TABLET
Generic
00904698861•Major Pharmaceuticals
$0.0555
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy